DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Meprobamate (Meprobamate) - Summary

 
 



MEPROBAMATE SUMMARY

Meprobamate is a white powder with a characteristic odor and a bitter taste. It is slightly soluble in water, freely soluble in acetone and alcohol, and sparingly soluble in ether.

Meprobamate tablets are indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety. Anxiety or tension associated with the stress of everyday life usually do not require treatment with an anxiolytic.

The effectiveness of meprobamate tablets in long-term use, that is, more than 4 months, has not been assessed by systematic clinical studies. The physician should periodically reassess the usefulness of the drug for the individual patient.


See all Meprobamate indications & dosage >>

NEWS HIGHLIGHTS

Media Articles Related to Meprobamate

Combining opioids with anti-anxiety medicines linked to greater risk of overdose
Source: Alcohol / Addiction / Illegal Drugs News From Medical News Today [2017.03.16]
Taking opioids (strong prescription painkillers) together with benzodiazepines (widely used to treat anxiety and sleep problems) is associated with greater risk of opioid overdose, finds a study in...

Low levels of 'anti-anxiety' hormone linked to postpartum depression
Source: Depression News From Medical News Today [2017.03.16]
In a small-scale study of women with previously diagnosed mood disorders, Johns Hopkins researchers report that lower levels of the hormone allopregnanolone in the second trimester of pregnancy...

Component of marijuana may help treat anxiety and substance abuse disorders
Source: Alcohol / Addiction / Illegal Drugs News From Medical News Today [2017.03.09]
Cannabidiol, a major component of cannabis or marijuana, appears to have effects on emotion and emotional memory, which could be helpful for treating anxiety-related and substance abuse disorders.

Antidepressants and anti-anxiety drugs linked to increased risk of hip fracture
Source: Anxiety / Stress News From Medical News Today [2017.03.09]
In a recent study, older individuals who had fallen and broken a hip used antidepressant and anti-anxiety medications more frequently than the general older population.

Athletes' symptom anxiety linked to risk of injury
Source: Anxiety / Stress News From Medical News Today [2017.03.02]
The anxiety experienced by elite athletes over illness symptoms is linked to the risk of being injured during competition and should be taken seriously, according to a study carried out at the IAAF...

more news >>

Published Studies Related to Meprobamate

Comparative abuse liability and pharmacological effects of meprobamate, triazolam, and butabarbital. [2003.06]
Implementation of regulations to control the prescribing of benzodiazepines in New York State in 1989 resulted in a 55% decrease in benzodiazepine prescribing, with a concomitant increase in the rates of prescribing older sedative-hypnotic compounds such as butabarbital (30% increase) and meprobamate (125% increase).

more studies >>

Reports of Suspected Meprobamate Side Effects

Toxicity TO Various Agents (28)Respiratory Arrest (15)Cardiac Arrest (15)Accidental Death (14)Drug Abuse (11)Completed Suicide (11)Death (5)Multiple Drug Overdose Accidental (5)Pulmonary Congestion (5)Pulmonary Oedema (4)more >>


Page last updated: 2017-03-16

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015